Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hydroxycut Recall Sheds Light On Pros And Cons Of AER System

This article was originally published in The Tan Sheet

Executive Summary

Identifying possible risks linked to dietary supplements - such as the recalled line of Hydroxycut weight-loss products - is challenging because FDA generally works with post-market information, an agency executive said
Advertisement

Related Content

DMAA Warnings Shed Light On FDA NDI Enforcement
Integrated Marketing, Healthy Food Will Drive Weight-Loss Sector Sales
Zicam Case Shows FDA Takes Defining Adverse Events Seriously
Sharfstein Defends FDA User Fees As Key To A New Food Safety System
First Year Of Mandatory Reports Shows Safety-Monitoring Value Of AER Data
Hydroxycut Recall Eyed As Trigger For Closer Look At Supplement AERs
Iovate recalls more Hydroxycut products
AER Label Guidance Holds To Requiring Full Addresses For OTCs, Supplements
Supreme Court Refuses Ephedra Case, Battle Against Risk-Benefit Continues
Supreme Court Refuses Ephedra Case, Battle Against Risk-Benefit Continues

Topics

Advertisement
UsernamePublicRestriction

Register

PS102870

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel